Sermorelin vs HGH
Sermorelin vs HGH: different products and different care decisions.
Sermorelin is a growth hormone-releasing hormone analogue: it prompts the pituitary to release growth hormone. HGH usually means human growth hormone itself; prescription somatropin supplies recombinant growth hormone. They are not interchangeable treatments. The FDA-approved somatropin product Zomacton has an adult growth hormone deficiency indication and requires physician supervision. The old FDA-approved sermorelin products were withdrawn from the market, while today's online compounded sermorelin products are not FDA-approved. Neither product is approved for general anti-aging. If you are investigating possible adult growth hormone deficiency, ask an endocrinologist about diagnosis and indicated treatment. If you are comparing an online sermorelin plan, this site can audit its product and bill, but it cannot infer that the plan substitutes for somatropin or improves longevity.
This comparison exists because readers search for the distinction. Search demand does not establish that either product works, belongs in the same provider table or should be prescribed. We have audited providers only for the side explicitly linked below.
| Question | Current compounded sermorelin offer | Prescription somatropin (HGH) |
|---|---|---|
| What is supplied? | A GHRH analogue intended to stimulate the body's GH release. | Recombinant human growth hormone supplied directly. |
| Current FDA-approved product? | The online compounded product is not FDA-approved; historical Geref products are discontinued. | Named somatropin products have FDA-approved indications, including adult GH deficiency for Zomacton. |
| Is either approved for general anti-aging? | No such indication for the current compounded offers. | No such indication in the cited Zomacton label. |
| What market is audited here? | Sourced US online sermorelin product and payment plans. | No somatropin provider, coverage or price ranking on this site. |
What is the difference between sermorelin and HGH?
Sermorelin is a GHRH analogue that stimulates endogenous growth hormone release. Somatropin is recombinant human growth hormone supplied as the drug itself. A milligram, response or monthly price on one side cannot be converted into an equivalent amount on the other.
The distinction also changes the reader's task: a suspected deficiency calls for a diagnostic and treatment discussion; a telehealth sermorelin offer calls for checking the exact compounded product and contract.
Is sermorelin or HGH FDA-approved for adults?
Zomacton's FDA label includes replacement of endogenous GH in adults with GH deficiency. That indication applies to the named somatropin product and population, not to every product marketed as HGH and not to anti-aging use.
Historical Geref sermorelin products had FDA approvals but were discontinued; FDA later determined they were not withdrawn for safety or effectiveness reasons. That historical status does not approve today's compounded sermorelin preparations. FDA does not review compounded drugs for safety, effectiveness and quality before marketing.
Which works better for growth hormone deficiency or anti-aging?
For diagnosed adult GH deficiency, the cited somatropin label supports an approved replacement treatment pathway. It does not establish that a wellness-focused sermorelin subscription is an equivalent alternative. A review of historical pediatric sermorelin studies reported no direct comparison at the recommended dose with somatropin; pediatric observations cannot answer an adult longevity question.
Neither the cited somatropin label nor the sermorelin sources establish general lifespan extension. This comparison therefore does not name an anti-aging winner or recommend a hormone treatment.
Can I compare sermorelin and HGH prices online?
A bare monthly price is not a comparable quote. A compounded sermorelin subscription has its own supplied quantity, first payment, renewal, labs, pharmacy and cancellation rules. Somatropin treatment for an indicated condition has a separate diagnostic, prescription and potentially insurance-dependent pathway.
Longevity Ranked audits the first set of plan terms, but has not audited a somatropin provider or coverage market. Use the linked sermorelin cost guide for sourced offers; obtain a separate complete quote and coverage determination for a named somatropin product rather than assuming one is cheaper.
For a broader peptide mechanism and research-status guide, read Best Peptide for That's sermorelin profile. This Longevity Ranked page covers the current care decision and plan terms.
Which sources support this comparison?
These sources were checked September 23, 2026. They define the product, population and regulatory boundaries used above; they do not determine individual suitability.
- Sermorelin clinical review: mechanism and pediatric evidence (2007)
- FDA Zomacton (somatropin) prescribing information (July 2025)
- FDA: discontinued Geref sermorelin determination (2013)
- FDA: understanding the risks of compounded drugs
- Historical GHRH versus growth hormone pediatric comparison (1989)
Popular X vs Y questions
Continue with another evidence comparison.
We publish a comparison when people are searching for the distinction, even when only one side has audited providers. Inclusion is not an endorsement.
Sermorelin vs tesamorelin
Compare sermorelin vs tesamorelin for fat loss and muscle claims, human study results, FDA status and safety. Understand EGRIFTA WR and compounded products.
Sermorelin vs ipamorelin
Sermorelin and ipamorelin use different receptors. Compare human studies, fat-loss and muscle claims, FDA concerns and the limits of combination claims.
Sermorelin vs CJC-1295
Compare sermorelin and CJC-1295 by product identity, duration claims, FDA status and evidence limits. Understand why CJC-1295 forms cannot be grouped together.
These are products marketed in the longevity category, not established lifespan-extension treatments. Compounded drugs are not FDA-approved. This publication compares public information; a clinician must assess individual suitability. How we compare.